Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 26, 2018

SELL
$37.84 - $69.96 $416,240 - $769,559
-11,000 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$46.49 - $60.51 $381,218 - $496,182
-8,200 Reduced 42.71%
11,000 $578,000
Q3 2017

Oct 30, 2017

BUY
$37.05 - $47.12 $711,360 - $904,704
19,200
19,200 $905,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.